Sort
25,944 grants matching “neurodegeneration”
GENOMIC ANALYSIS OF ALZHEIMERS DISEASE GENES
$227,301University Of Washington · R01 · FY2000 · AG
Amyloid PET and blood biomarker supplement to the Delirium Program Project
$227,288Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2021 · AG
Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma
$227,287Yvonne Ou · University Of California, San Francisco · K08 · FY2012 · EY
Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma
$227,287Yvonne Ou · University Of California, San Francisco · K08 · FY2014 · EY
Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma
$227,287Yvonne Ou · University Of California, San Francisco · K08 · FY2013 · EY
Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma
$227,287Yvonne Ou · University Of California, San Francisco · K08 · FY2015 · EY
Compartmentalized neurodegeneration of retinal ganglion cells in glaucoma
$227,287Yvonne Ou · University Of California, San Francisco · K08 · FY2016 · EY
Whole brain multimodal microscopy of an apoptosis reporter mouse
$227,258Peter Jeff Nicholls · Duke University · R21 · FY2013 · NS
Development and characterization of an AAV-based tool to functionally ablate astrocytic mitochondria in specific brain regions in vivo
$227,250Rahul Srinivasan · Texas A&M University Health Science Ctr · R21 · FY2022 · NS
Peripheral Glial Response to Sensory Nerve Degeneration
$227,250Mark M Voigt · Saint Louis University · R21 · FY2015 · NS
Cathepsin-L mediated remodeling of the nuclear proteome
$227,250Susana Gonzalo Hervas · Saint Louis University · R21 · FY2025 · AG
A BBB-permeable neurotrophic polysaccharide, midi-GAGR
$227,250Joshua Jin-Hyouk Park · University Of Toledo Health Sci Campus · R21 · FY2016 · AG
CYANIDE NEUROTOXICITY--NECROTIC AND APOPTOTIC CELL DEATH
$227,212Purdue University West Lafayette · R01 · FY2002 · ES
Mitotic Mechanisms in Alzheimer's Disease
$227,200University Of Washington · R01 · FY2005 · AG
Project 3: Pesticide Mechanisms and PD: In Vivo Studies In Rodents
$227,065Marie-Francoise S Chesselet · University Of California Los Angeles · P01 · FY2011 · ES
Protein and small-molecule tools to probe the conformational dependence of the VCP/p97 protein-protein interaction network--Equipment Supplement
$226,990Michelle Arkin · University Of California, San Francisco · R01 · FY2020 · GM
Novel strategies for glutamate clearance in a glia-deprived synaptic hub: Lessons from C. elegans
$226,950Itzhak Mano · City College Of New York · R21 · FY2017 · NS
In Vivo Lentiviral Gene Therapy for Hurler Syndrome
$226,946Chester B Whitley · University Of Minnesota · P01 · FY2014 · HD
Neuroprotection via XIAP gene therapy in Huntington's disease
$226,800Michael G Kaplitt · Weill Medical Coll Of Cornell Univ · R21 · FY2006 · NS
Ubiquitin-Dependent Proteolysis: Specificity & Mechanism
$226,774Keith D Wilkinson · Emory University · R01 · FY2009 · GM
Project 3: Dynamic Networks
$226,693Randy L Buckner · Massachusetts General Hospital · P01 · FY2017 · AG
Experimental Therapeutic Strategies for ALS
$226,648Serge E Przedborski · Columbia University Health Sciences · P01 · FY2007 · NS
Heterogeneity in toxicity of oligomeric amyloid beta and neuronal resilience in Alzheimer disease
$226,628Andrew Michael Stern · Brigham And Women'S Hospital · K08 · FY2023 · NS
Innate immune dysregulation in Alzheimer's disease modeled in Drosophila
$226,596Marc Tatar · Brown University · R21 · FY2020 · AG
A Mouse Model for Braak I/II Alzheimer's Pathology
$226,590Zhen Huang · University Of Wisconsin-Madison · R21 · FY2024 · AG